|
GALC expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.504200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.075800E-01 |
| Normal-vs-Stage2 |
1.757210E-01 |
| Normal-vs-Stage3 |
8.319800E-03 |
| Normal-vs-Stage4 |
7.447300E-04 |
| Stage1-vs-Stage2 |
8.047500E-02 |
| Stage1-vs-Stage3 |
1.879210E-03 |
| Stage1-vs-Stage4 |
1.357320E-04 |
| Stage2-vs-Stage3 |
6.439000E-01 |
| Stage2-vs-Stage4 |
2.193400E-01 |
| Stage3-vs-Stage4 |
2.898800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.454820E-01 |
| Normal-vs-AfricanAmerican |
3.039700E-02 |
| Normal-vs-Asian |
4.094800E-01 |
| Caucasian-vs-AfricanAmerican |
2.230800E-01 |
| Caucasian-vs-Asian |
8.543800E-01 |
| AfricanAmerican-vs-Asian |
7.427400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.239800E-02 |
| Normal-vs-Female |
3.759800E-01 |
| Male-vs-Female |
3.567200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.883800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.761640E-01 |
| Normal-vs-Age(61-80Yrs) |
1.719000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.630800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.465380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.130570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.000400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.627000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.369200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.479600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.043880E-03 |
| Normal-vs-Grade 2 |
3.437800E-01 |
| Normal-vs-Grade 3 |
7.321600E-03 |
| Normal-vs-Grade 4 |
1.59359999973852E-07 |
| Grade 1-vs-Grade 2 |
4.726100E-02 |
| Grade 1-vs-Grade 3 |
5.756200E-04 |
| Grade 1-vs-Grade 4 |
3.8886999997878E-07 |
| Grade 2-vs-Grade 3 |
1.754030E-04 |
| Grade 2-vs-Grade 4 |
1.37230005137212E-09 |
| Grade 3-vs-Grade 4 |
2.482500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.857520E-02 |
| Normal-vs-ccB subtype |
4.0503000000025E-05 |
| ccA subtype-vs-ccB subtype |
6.20500317793926E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.321800E-01 |
| Normal-vs-N1 |
2.706500E-02 |
| N0-vs-N1 |
3.808100E-02 |
|
|
